Relevant bibliographies by topics / Anti-mycobacterial

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers

Academic literature on the topic 'Anti-mycobacterial'

Author: Grafiati
Published: 2 June 2025
Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Anti-mycobacterial.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Anti-mycobacterial"

1

Muhammed, Sirwan Muhsin. "Previously licensed anti-mycobacterial drugs: a re-appraisal." Journal of Zankoy Sulaimani - Part A 18, no. 2 (2016): 173–96. http://dx.doi.org/10.17656/jzs.10513.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Broadley, S. J., P. A. Jenkins, J. R. Furr, and A. D. Russell. "Anti-mycobacterial activity of biocides." Letters in Applied Microbiology 13, no. 3 (1991): 118–22. http://dx.doi.org/10.1111/j.1472-765x.1991.tb00586.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Carta, Antonio, Sandra Piras, Michele Palomba, Daniela Jabes, Paola Molicotti, and Stefania Zanetti. "Anti-Mycobacterial Activity of Quinolones. Triazoloquinolones a New Class of Potent Anti-Mycobacterial Agents." Anti-Infective Agents in Medicinal Chemistry 7, no. 2 (2008): 134–47. http://dx.doi.org/10.2174/187152108783954641.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Almehmadi, Mazen, and Mohammad Asif. "In vitro anti-mycobacterial activity of 3-(6-methylbenzothiazol-2-yl)-2-arylthiazolidin-4-ones." INDIAN JOURNAL OF HETEROCYCLIC CHEMISTRY 35, no. 02 (2025): 525. https://doi.org/10.59467/ijhc.2025.35.525.

Full text
Abstract:
3-(6-Methylbenzothiazol-2-yl)-2-arylthiazolidin-4-ones (2a-h) have been synthesized by reacting substituted- 2-aminobenzothiazoles with appropriate aryl aldehydes followed by condensation with mercaptoacetic acid. The synthesized compounds were evaluated for their in vitro anti-mycobacterial activity using the Microplate Alamar Blue Assay method and compared with the standard drugs isoniazid, ethambutol, and pyrazinamide. Compounds 2c and 2e-h exhibited moderate activity at a concentration of 25 μg/mL compared to the standard drugs. Three compounds 2a, 2b, and 2d exhibited activity at a concen
APA, Harvard, Vancouver, ISO, and other styles
5

Anwar, S., C. F. Turienzo, L. Tsang, et al. "Impact of helminth co-infection and treatment on mycobacterial growth inhibition in UK migrants with TB infection." IJTLD OPEN 2, no. 4 (2025): 217–23. https://doi.org/10.5588/ijtldopen.24.0528.

Full text
Abstract:
<sec><title>BACKGROUND</title>TB and helminth infections are co-endemic in many parts of the world. This has led to the hypothesis that immunomodulation due to helminth infections could adversely affect the ability to control Mycobacterium tuberculosis infection. Anti-helminthic treatment has been associated with improved anti-mycobacterial cellular responses and decreases in the frequency of regulatory T-cells. We therefore investigated how control of mycobacterial growth and anti-mycobacterial immune responses are modulated in helminth and TB co-infected individuals using a
APA, Harvard, Vancouver, ISO, and other styles
6

Teng, Tieshan, Jiafa Liu, and Hongping Wei. "Anti-Mycobacterial Peptides: From Human to Phage." Cellular Physiology and Biochemistry 35, no. 2 (2015): 452–66. http://dx.doi.org/10.1159/000369711.

Full text
Abstract:
Mycobacterium tuberculosis is the major pathogen of tuberculosis (TB). With the growing problem of M. tuberculosis resistant to conventional antibiotics, especially multi-drug resistant tuberculosis (MDR-TB) and extensively-drug resistant tuberculosis (XDR-TB), the need for new TB drugs is now more prominent than ever. Among the promising candidates for anti-TB drugs, anti-mycobacterial peptides have a few advantages, such as low immunogenicity, selective affinity to prokaryotic negatively charged cell envelopes, and diverse modes of action. In this review, we summarize the recent progress in
APA, Harvard, Vancouver, ISO, and other styles
7

Mukomura, Junya, Hiroki Nonaka, Hiromasa Sato, Maho Kishimoto, Masayoshi Arai, and Naoyuki Kotoku. "Anti-Mycobacterial N-(2-Arylethyl)quinolin-3-amines Inspired by Marine Sponge-Derived Alkaloid." Molecules 27, no. 24 (2022): 8701. http://dx.doi.org/10.3390/molecules27248701.

Full text
Abstract:
The synthesis and evaluation of simplified analogs of marine sponge-derived alkaloid 3-(phenethylamino)demethyl(oxy)aaptamine were performed to develop novel anti-mycobacterial substances. Ring truncation of the tricyclic benzo[de][1,6]-naphthyridine skeleton effectively weakened the cytotoxicity of the natural product, and the resulting AC-ring analog exhibited good anti-mycobacterial activity. A structure–activity relationship (SAR) study, synthesizing and evaluating some analogs, demonstrated the specificity and importance of the N-(2-arylethyl)quinolin-3-amine skeleton as a promising scaff
APA, Harvard, Vancouver, ISO, and other styles
8

Chopra, I., and P. Brennan. "Molecular action of anti-mycobacterial agents." Tubercle and Lung Disease 78, no. 2 (1998): 89–98. http://dx.doi.org/10.1016/s0962-8479(98)80001-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Yamamoto, S., I. Toida, N. Watanabe, and T. Ura. "Anti-mycobacterial activities of pyrazinamide analogues." Tubercle and Lung Disease 75 (June 1994): 42–43. http://dx.doi.org/10.1016/0962-8479(94)90840-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Cappoen, Davie, Jure Vajs, Cynthia Uythethofken, et al. "Anti-mycobacterial activity of 1,3-diaryltriazenes." European Journal of Medicinal Chemistry 77 (April 2014): 193–203. http://dx.doi.org/10.1016/j.ejmech.2014.02.065.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Anti-mycobacterial"

1

Senior, Suzanne J. "Anti-mycobacterial agents based on thiolactomycin." Thesis, University of Newcastle Upon Tyne, 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.427377.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Lange, Shannon Marie. "L-Citrulline Metabolism Orchestrates Anti-mycobacterial Immunity." University of Cincinnati / OhioLINK, 2017. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1511882575584058.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Gallant, Caroline J. "Functional and genetic dissection of anti-mycobacterial immunity." Thesis, McGill University, 2009. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=66735.

Full text
Abstract:
Tuberculosis (TB) is a major global health problem with an estimated 2 billion people worldwide infected with M. tuberculosis, the causative agent of TB, and 9.2 million new cases of active TB disease reported in 2008. Despite the enormity of the problem, little is known about the anti-mycobacterial immune responses used to detect TB infection. The aim of my studies was to investigate how host factors impact on anti-mycobacterial immune responses and to evaluate if these responses can provide clues about host susceptibility to infection and progression to disease. Healthy nuc
APA, Harvard, Vancouver, ISO, and other styles
4

Ballell, Lluis. "Synthesis and evaluation of new anti-mycobacterial agents." Thesis, University of East Anglia, 2003. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.398800.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Douglas, James Dogeron. "Anti-mycobacterial agents based on thiolactomycin and isoxyl." Thesis, University of Newcastle Upon Tyne, 1998. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.265483.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Wozniak, Teresa Maria. "Manipulating anti-mycobacterial immunity with immune-stimulating cytokines." Thesis, The University of Sydney, 2007. https://hdl.handle.net/2123/28089.

Full text
Abstract:
Infection with Mycobacterium tuberculosis and the resulting developmentof Tubercglosis (TB) is a major heath concern worldwide. The development of drug resistant strains and co— infection with HIV has hampered the control of TB and the global movement of people makes TB a significant health problem. The vaccine currently available for the prevention of TB is an attenuated strain of Mycobacterium bovis, bacillus Calmette Guérin (BCG). It is a successful vaccine for the prevention of childhood infection, but its efficacy against the highly contagious, pulmonary form of the disease is variable. T
APA, Harvard, Vancouver, ISO, and other styles
7

Bhowruta, Veemal. "Anti-Mycobacterial Agents Targeting Enzymes Involved in Mycolic Acid Biosynthesis." Thesis, University of Birmingham, 2008. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.521933.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Redford, Paul Stuart. "Regulatory mechanisms inhibiting anti-mycobacterial immunity following Mycobacterium tuberculosis infection." Thesis, University College London (University of London), 2007. http://discovery.ucl.ac.uk/1445023/.

Full text
Abstract:
The work reported in this thesis addresses the regulatory factors that function to limit the initiation of protective immune responses following exposure to the bacterium Mycobacterium tuberculosis (MTb). Control and clearance of intracellular pathogens, such as MTb, is dependent on the cytokine Tumour Necrosis Factor (TNF) and induction of a T-helper 1 (Thl) response, which is characterised by production of IFN-gamma driven by interleukin (IL)-12. In other infection models the presence of the immunosuppressive cytokine IL-10 in the local milieu has been shown to down-regulate Thl responses th
APA, Harvard, Vancouver, ISO, and other styles
9

Madikane, Eliya Vukani. "The isolation of anti-mycobacterial compounds from South African medicinal plants." Doctoral thesis, University of Cape Town, 2005. http://hdl.handle.net/11427/3289.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Dashti, Yousef. "The Cryptic Genome, NMR Fingerprinting and Chemoinformatics Towards Anti-mycobacterial Discovery." Thesis, Griffith University, 2016. http://hdl.handle.net/10072/365648.

Full text
Abstract:
Secondary metabolites and their derivatives from microorganisms are a source of many important drugs. Indeed almost half of the antibiotics in the market are actinomycetes sourced natural products. However, advances in genome sequencing have revealed that actinomycetes are capable of producing still a far greater number of metabolites and potential drugs. The machinery for making the majority of secondary metabolites is silent when actinomycetes are grown under standard culture conditions. Chapters 2 and 3 of this thesis focused on two different approaches to de- silence bacterial cryptic gen
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Anti-mycobacterial"

1

Fazal, Nadeem. Effector mechanisms of human anti-mycobacterial immunity. University of Birmingham, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Watts, Richard A., and Eleana Ntatsaki. Miscellaneous vasculitides. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199642489.003.0137.

Full text
Abstract:
The vasculitides are a group of relatively rare conditions with a broad spectrum of clinical presentations that can cause significant morbidity and mortality. Classification of the vasculitic syndromes is done according to the size of the vessels affected and also the presence of anti-neutrophil cytoplasmic antibodies (ANCA). Vasculitides can be either primary or secondary to an underlying systemic disease, malignancy, or infection. This chapter covers the spectrum of the secondary vasculitides; some of the non-ANCA-associated primary vasculitides and miscellaneous types of vasculitic syndrome
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Anti-mycobacterial"

1

Teo, Stephen P. "Anti-Mycobacterial Plants." In Medicinal Plants of Borneo. CRC Press, 2021. http://dx.doi.org/10.1201/9780429470332-3-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Bhaskar, Ashima, Ved Prakash Dwivedi, and Vinay Kumar Nandicoori. "Eliminating Mycobacterial Persistence: Novel Targets for Anti-TB Therapy." In Pathogenicity and Drug Resistance of Human Pathogens. Springer Singapore, 2019. http://dx.doi.org/10.1007/978-981-32-9449-3_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

O’Brien, L., B. Roberts, and P. W. Andrew. "In Vitro Interaction of Mycobacterium tuberculosis and Macrophages: Activation of Anti-mycobacterial Activity of Macrophages and Mechanisms of Anti-mycobacterial Activity." In Current Topics in Microbiology and Immunology. Springer Berlin Heidelberg, 1996. http://dx.doi.org/10.1007/978-3-642-80166-2_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Kim, Hyo-Sun, Ella S. M. Ng, Ruixiang Blake Zheng, Randy M. Whittal, David C. Schriemer, and Todd L. Lowary. "Studies toward the Development of Anti-Tuberculosis Vaccines Based on Mycobacterial Lipoarabinomannan." In ACS Symposium Series. American Chemical Society, 2008. http://dx.doi.org/10.1021/bk-2008-0989.ch009.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Kumar, Ankur, and Kuldeep K. Roy. "Computer-Aided Drug Design of Potential Anti-Tubercular Drug Targeting the Mycobacterial F-Type ATP Synthase Enzyme." In Global Trends in Health, Technology and Management. Springer Nature Switzerland, 2024. https://doi.org/10.1007/978-3-031-75457-9_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Finberg, Robert W., and Roy Guharoy. "Clinical Approach to Treatment of Mycobacterial Infections." In Clinical Use of Anti-infective Agents. Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4614-1068-3_18.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Finberg, Robert W., and Roy Guharoy. "Clinical Approach to Treatment of Mycobacterial Infections." In Clinical Use of Anti-infective Agents. Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-67459-5_22.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

A. A, Yelmate, Narayanpure D.V, Suryawanshi S.D, and Nisale A.D. "Promising Anti-mycobacterial Potentiality of Indian Noteworthy Plant Argemone mexicana Linn." In Pharmaceutical Science: New Insights and Developments Vol. 4. BP International, 2025. https://doi.org/10.9734/bpi/psnid/v4/4643.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Baker, William R., Lester A. Mitscher, Taraq M. Arain, Ribhi Shawar, and C. Kendall Stover. "Chapter 17. Recent Advances in the Chemistry and Biology of Anti-mycobacterial Agents." In Annual Reports in Medicinal Chemistry. Elsevier, 1996. http://dx.doi.org/10.1016/s0065-7743(08)60456-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Hamem, Manal NK, PV Sangeeta Guruvelli, Sony Priya Kurati, and Murali Krishna Kumar Muthyala. "Identification, Modelling and Docking Studies on Sert Like Mycobacterial Protein as a Possible Anti TB Drug Target." In Current Trends in Drug Discovery, Development and Delivery (CTD4-2022). Royal Society of Chemistry, 2023. http://dx.doi.org/10.1039/9781837671090-00123.

Full text
Abstract:
Recent discovery of potent anti TB activity in sertraline, a popular antidepressant drug which acts via selective serotonin reuptake inhibiton, enthused us to search for possible presence of related proteins in Mycobacterium tuberculosis. We used bioinformatic tools and we used Serotonin Reuptake Receptor of 5-HT protein sequence as query and search the Mycobacterium tuberculosis database using protein blast tool. The mycobacterial protein SGC57945.1, a sodium dependant transporter, is selected based on score (identical percentage-25%; similarity-45%) and pursued for homology modelling and bin
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Anti-mycobacterial"

1

Pennington, K., and P. Escalante. "Clinical Characteristics and Outcomes of Patients Undergoing Anti-Mycobacterial Therapy versus No Anti- Mycobacterial Therapy for Mycobacterium Avium Complex Pulmonary Disease." In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2537.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Mali, Suraj N., and Anima Pandey. "Naturally Occurring Green Tea Polyphenols as Anti-Mycobacterial Agents." In ECMS 2021. MDPI, 2021. http://dx.doi.org/10.3390/ecms2021-10844.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Mendonça-Júnior, Francisco, Rodrigo Araújo, Karla Luna, et al. "Synthesis and Anti-mycobacterial evaluation of coumarin derivatives." In MOL2NET 2017, International Conference on Multidisciplinary Sciences, 3rd edition. MDPI, 2017. http://dx.doi.org/10.3390/mol2net-03-05061.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Madikizela, B., and L. McGaw. "Anti-mycobacterial, cytotoxicity and genotoxicity effects of five traditionally used anti-tuberculosis plants in South Africa." In GA 2017 – Book of Abstracts. Georg Thieme Verlag KG, 2017. http://dx.doi.org/10.1055/s-0037-1608563.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Winthrop, Kevin L., Roger Baxter, Liyan Liu, et al. "Mycobacterial Disease In Rheumatoid Arthritis Patients Who Use Anti-tumor Necrosis Therapy." In American Thoracic Society 2010 International Conference, May 14-19, 2010 • New Orleans. American Thoracic Society, 2010. http://dx.doi.org/10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a2603.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Scotti, Francesca, Sanjib Bhakta, and John P. Malkinson. "Lasso Peptides and Murein Peptide Ligase Inhibitors as Novel Anti-Mycobacterial Agents." In The 24th American Peptide Symposium. Prompt Scientific Publishing, 2015. http://dx.doi.org/10.17952/24aps.2015.193.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

SYAHPUTRA, GITA. "Anti-mycobacterial activity of methanol plants extract to against Mycobacterium bovis and Mycobacterium smegmatis." In Seminar Nasional Masyarakat Biodiversitas Indonesia. Masyarakat Biodiversitas Indonesia, 2016. http://dx.doi.org/10.13057/psnmbi/m020211.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

NAQVI, ARSHI, MOHD SHAHNAWAZ, and ASIF NAQVI. "N'-(Substitutedbenzylidene)-3-(2-nitrophenylamino)-3-oxopropanehydrazide: Synthesis, Molecular Docking Studies and Anti-mycobacterial Screenings." In The 16th International Electronic Conference on Synthetic Organic Chemistry. MDPI, 2012. http://dx.doi.org/10.3390/ecsoc-16-01122.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Winthrop, Kevin L., Roger Baxter, Liyan Liu, et al. "Mycobacterial Disease In Patients With Inflammatory Autoimmune Diseases Who Use Anti-Tumor Necrosis Factor Therapy." In American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a2397.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

SHAHNAWAZ, MOHD, ARSHI NAQVI, and ASIF NAQVI. "Synthesis, Molecular Docking Studies and Anti-mycobacterial Evaluation of N-(Malon-substituted-anilic)-4-phenyl Thiosemicarbazide." In The 16th International Electronic Conference on Synthetic Organic Chemistry. MDPI, 2012. http://dx.doi.org/10.3390/ecsoc-16-01114.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Anti-mycobacterial' for particular source types:
Journal articles Dissertations / Theses
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography